A Study to Look at Tapentadol Oral Solution in Children and Adolescents in Pain
Status:
Completed
Trial end date:
2019-03-14
Target enrollment:
Participant gender:
Summary
The purpose of the study was to evaluate the efficacy of tapentadol oral solution, based on
the total amount of supplemental opioid analgesic used over 12 hours or 24 hours after
initiation of investigational medicinal product (IMP) in children and adolescents who had
undergone surgery that would produce moderate to severe pain during opioid treatment.